Direkt zum Inhalt
Merck

1.07071

SAFC

Neotam

EMPROVE® ESSENTIAL, NF

Arzneimittelherstellung

Synonym(e):

N-[N-(3,3-Dimethylbutyl)-L-α-aspartyl]-L-phenylalanin-1-methylester

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise


About This Item

Empirische Formel (Hill-System):
C20H30N2O5
CAS-Nummer:
Molekulargewicht:
378.46
Beilstein:
8352678
MDL-Nummer:
UNSPSC-Code:
85151701

Qualität

GMP
Halal
Kosher

Qualitätsniveau

Agentur

NF

Beschreibung

GMO free

Produktlinie

EMPROVE® ESSENTIAL

Form

fine powder

mp (Schmelzpunkt)

80-83 °C

Anwendung(en)

pharmaceutical
solid formulation

Lagertemp.

15-25°C

SMILES String

COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(O)=O)NCCC(C)(C)C

InChI

1S/C20H30N2O5/c1-20(2,3)10-11-21-15(13-17(23)24)18(25)22-16(19(26)27-4)12-14-8-6-5-7-9-14/h5-9,15-16,21H,10-13H2,1-4H3,(H,22,25)(H,23,24)/t15-,16-/m0/s1

InChIKey

HLIAVLHNDJUHFG-HOTGVXAUSA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Allgemeine Beschreibung

As a high-intensity sweetener with an excellent stability and a clean, sugar-like taste profile, neotame is your ideal tool for taste optimization. Due to its exceptional sweetness with a factor 8,000 to 13,000 greater than sucrose and 40-60 greater than aspartame, it is efficient in use and costs.
Neotame is part of our Emprove® Program and offered with extensive documentation facilitating compliance of your pharma product, full supply chain transparency and risk mitigation. The product withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

Anwendung

From orally disintegrating tablets (ODTs), effervescent tablets to syrups and oral films – neotame can be applied to a wide range of pharmaceutical products and enables safe and heat-stable formulations.

Leistungsmerkmale und Vorteile

  • Excellent sugar-like taste profiles
  • Masking bitter aftertaste and medical off-notes with ease
  • High sweetness potency offers improved cost-efficiency
  • Enhanced stability
  • Non-cariogenic and suitable for diabetics and patients with phenylketonuria

Verpackung

1070711000 / 1 kg / Polyethylene bottle
1070710250 / 250 g / Polyethylene bottle
1070710001 / 3 x 10 g / PE bottles (in cardboard box)

Rechtliche Hinweise

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany

Anwendung

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable


Analysenzertifikate (COA)

Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Artikel

Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.

Verwandter Inhalt

Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.